WINNIPEG, MB, Sept. 26,
2022 /CNW/ - This release is being issued in
connection with the filing of an early warning report (the
"Early Warning Report") pursuant to the requirements of
National Instrument 62-103 – The Early Warning System and
Related Take-Over Bid and Insider Reporting Issues regarding
the change in the ownership and control of common shares (the
"Common Shares") of Medicure Inc. (the "Issuer") by
Dr. Albert D. Friesen ("Dr.
Friesen"). The Issuer's head office address and Dr.
Friesen's business address is 2-1250 Waverley Street, Winnipeg, Manitoba, Canada, R3T 6C6.
Since December 31, 2019, Dr.
Friesen has acquired Common Shares exceeding 2% of the outstanding
Common Shares of the Issuer. This 2% reporting threshold was
reached on September 22, 2022 with
the acquisition of 14,100 Common Shares representing approximately
0.14% of the Issuer's outstanding Common Shares (the
"Acquisition"). The Common Shares were purchased at a price
of $1.00 per share through the
facilities of the TSX Venture Exchange.
Immediately prior to the Acquisition, Dr. Friesen had ownership
of, directly and indirectly, or exercised control or direction
over, 2,539,927 Common Shares (representing 24.78% of the issued
and outstanding Common Shares of the Issuer).
Immediately after completion of the Acquisition, Dr. Friesen has
ownership of, directly and indirectly, or exercises control or
direction over, 2,554,027 Common Shares (representing 24.91% of the
issued and outstanding Common Shares of the Issuer).
Dr. Friesen also holds options entitling him to purchase an
aggregate of 146,500 Common Shares upon exercise of the options,
resulting in Dr. Friesen having ownership of, directly and
indirectly, or exercising control or direction over 2,700,527
Common Shares (representing 25.97% of the issued and outstanding
Common Shares of the Issuer on a partially diluted basis).
Dr. Friesen holds securities of the Issuer for investment
purposes. He may, from time to time and depending on market
and other conditions, acquire additional Common Shares and/or other
equity, debt or other securities or instruments of the Issuer in
the open market or otherwise, and reserves the right to dispose of
any or all of the securities in the open market or otherwise at any
time and from time to time, and to engage in similar transactions
with respect to the securities, the whole depending on market
conditions, the business and prospects of the Issuer and other
relevant factors.
The Early Warning Report will be filed by Dr. Friesen in
accordance with applicable securities laws. To obtain a copy of the
Early Warning Report, please contact Medicure Inc. at 204-487-7412,
2-1250 Waverley Street, Winnipeg,
Manitoba, Canada, R3T 6C6, Email: info@medicure.com.
View original
content:https://www.prnewswire.com/news-releases/early-warning-news-release--dr-albert-d-friesens-holdings-in-medicure-inc-301632523.html
SOURCE Dr. Albert D. Friesen